文献速递临床试验与 GCP基础与转化研究

针刺治疗颈动脉粥样硬化斑块:一项预试验随机单盲对照临床试验的研究方案

Acupuncture treatment for carotid atherosclerotic plaques: study protocol for a pilot randomized, single blinded, controlled clinical trial.
PubMed 文献 · Trials · 2020-09-07

本研究为在中国开展的三臂随机单盲对照预试验,拟纳入105例颈动脉粥样硬化斑块患者,按1:1:1随机分为针刺组、假针刺组和药物组,每组35例。

要点

  • 针刺可能为颈动脉粥样硬化斑块患者提供安全、可长期维持的替代疗法。
  • 主要结局采用三维超声测量斑块体积和灰阶中位数评估斑块负荷与成分。
  • 采用意向性分析和符合方案集分析两种原则评估疗效。

核心结论

  • 本试验旨在评估针刺缓解颈动脉粥样硬化斑块的疗效与可靠性,为临床治疗提供新思路。

研究设计与样本

  • 在中国开展的三臂随机单盲对照预试验,按1:1:1随机分为针刺组、假针刺组和药物组。
  • 计划纳入105例颈动脉粥样硬化斑块患者,每组35例,自愿入组。

关键数值与推荐

  • 主要结局为双侧颈动脉总斑块体积和灰阶中位数两项三维超声指标。
  • 次要结局包括内中膜厚度、血脂水平、载脂蛋白A-IV水平、血小板计数、纤维蛋白原和血小板聚集率。
  • 所有结局在治疗前、治疗后及12周随访后评估。
  • 采用符合方案集和意向性治疗分析原则。

临床怎么用

  • 若证实有效,针刺可作为颈动脉粥样硬化斑块患者安全、可长期维持的治疗选择。

局限性

  • 本研究为预试验,样本量较小(105例),结果需进一步大样本验证。
  • 试验为单盲设计,可能存在实施偏倚。
  • 试验注册为回顾性注册。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid atherosclerosis disease (CAD) is generally associated with the occurrence of cardiovascular and cerebrovascular accidents. However, CAD has not been taken seriously enough in the clinic, which, coupled with the single treatment and prevention of CAD, has led to a generally low level of patient compliance. Therefore, acupuncture is expected to be a safe and effective therapy that can be maintained in the long term for patients with CAD. The study objective is to evaluate the efficiency and reliability of acupuncture to relieve CAD and provide a new therapeutic idea for the clinical treatment of CAD. METHODS: This is a three-arm randomized clinical trial in China. Three groups (TA, SA, and MC) will be randomly allocated at a 1:1:1 ratio. The study will enrol 105 cervical atherosclerosis plaque patients in total on a voluntary basis, with 35 patients in each group. The treatment will last for 12 weeks, with two treatments per week for twenty-four treatments in total. RESULTS: Two 3D ultrasound indicators will be measured as the primary outcomes: the total plaque volume (PV) of the carotid artery on each side and the grey-scale median (GSM). The secondary outcomes will include intima-media thickness (IMT), lipid levels, apolipoprotein A-IV level, platelet count (PLT), fibrinogen (FIB), and platelet aggregation rate (PAR). All the outcomes will be assessed before treatment, after treatment, and after a 12-week follow-up period. This study will utilize per-protocol (PP) and intention-to-treat (ITT) analysis principles. CONCLUSIONS: This trial is to evaluate the efficacy and reliability of acupuncture in relieving carotid atherosclerotic plaques by establishing acupuncture (TA), sham acupuncture (SA), and medication (MC) groups. ETHICS AND DISSEMINATION: This study was approved by the Institutional Ethics Committee of Guangdong Provincial Hospital of Traditional Chinese Medicine (no. YF2018-107-01). All data and findings will be provided by the principal investigator via email. TRIAL REGISTRATION: ChiCTR, ChiCTR1800019259 . Registered on 1 November 2018-retrospectively registered, http://www.chictr.org.cn/index.aspx.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhou J, Zhao L, Meng L, et al. Acupuncture treatment for carotid atherosclerotic plaques: study protocol for a pilot randomized, single blinded, controlled clinical trial. Trials. 2020. PMID: 32894190. doi:10.1186/s13063-020-04709-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。